Related Experiment Video
Updated: Aug 17, 2026

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
Macrophages and progressive tubulointerstitial disease
Kevin Sean Eardley1, Paul Cockwell
1Department of Nephrology, University Hospital Birmingham NHS Trust, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Abstract:
Macrophages and progressive tubulointerstitial disease. In chronic renal disease, tubulointerstitial inflammation and injury is associated with infiltrating macrophages. As a consequence of primary injury, proteinuria, chronic hypoxia, and glomerular-derived cytokines may all differentially modulate the expression of factors that promote macrophage recruitment. In addition to adhesion molecules and chemokines, products of complement system and renin-angiotensin system activation may direct this process. Once present at interstitial sites, macrophages interact with resident cells and extracellular matrix to generate a proinflammatory microenvironment that amplifies tissues injury and promotes scarring. There is now increasing evidence for the efficacy of interventions directed against factors that recruit, activate, or are produced by macrophages. A detailed understanding of the biology of this area may lead to the further development of therapies that will improve the outcome of renal disease.
Insights
Macrophages drive chronic kidney disease progression by causing inflammation and scarring. Targeting these immune cells offers a promising therapeutic strategy for improving kidney disease outcomes.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Tubulointerstitial inflammation and injury in chronic kidney disease (CKD) are linked to infiltrating macrophages.
- Factors like proteinuria, hypoxia, and cytokines modulate macrophage recruitment in CKD.
- Complement system and renin-angiotensin system activation influence macrophage infiltration.
Purpose of the Study:
- To explore the role of macrophages in progressive tubulointerstitial disease within CKD.
- To understand the mechanisms of macrophage recruitment and activation in the renal interstitium.
- To highlight the therapeutic potential of targeting macrophage-related pathways in CKD.
Main Methods:
- Review of existing literature on macrophage biology in renal disease.
- Analysis of factors influencing macrophage recruitment (e.g., chemokines, complement, renin-angiotensin system).
- Examination of macrophage interactions with renal cells and extracellular matrix.
Main Results:
- Macrophages create a proinflammatory microenvironment, amplifying kidney injury and fibrosis.
- Various factors, including proteinuria and hypoxia, contribute to macrophage accumulation.
- Evidence supports the efficacy of targeting macrophage-related pathways.
Conclusions:
- Macrophages are key players in the pathogenesis of progressive tubulointerstitial disease in CKD.
- Interventions targeting macrophage recruitment, activation, or products show therapeutic promise.
- Further understanding of macrophage biology can lead to improved CKD treatments.
Related Concept Videos
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Diabetic Nephropathy
Inflammatory Bowel Disease II: Ulcerative Colitis
Tuberculosis

